Lupin 2023

Issue 11-23-2009

Kerr Drug stretches horizons for Rx

Kerr Drug stretches horizons for Rx

CHAPEL HILL, N.C. — Kerr Drug this month took another step to advance pharmacy. The chain opened a store here with a room for pharmacogenomics, the study of how a patient’s genes affect medication efficacy. The room is one of five in the store’s Community Healthcare Center for clinical pharmacy, another Kerr innovation. The other

Senate leaders unveil health care reform bill

WASHINGTON — Senate Majority Leader Harry Reid (D., Nev.) introduced a health care reform bill in that chamber earlier this month, setting the stage for a debate there and the eventual merging of the Senate measure with the bill passed in the House on November 7. At presstime, however, Senate leaders were unsure whether they

Drug chains step up marketing efforts

NEW YORK — Drug chains across the country and in Canada are stepping up their promotional efforts this holiday season, offering everything from sophisticated catalogs and in-store flyers to money-saving programs. CVS Caremark Corp., for example, recently mailed out an 84-page catalog offering deals on hundreds of products and ways to earn Extra Bucks from

More expansive role for pharmacy eyed in Canada

TORONTO — “In transition,” “crisis,” “opportunity,” “danger,” “a new paradigm”: Those were the words and phrases that were liberally sprinkled through the remarks of 10 speakers who, in an intense six-hour session, addressed the delegates to the 2009 Innovation In Pharmacy conference here earlier this month. Organized by the Canadian Association of Chain Drug Stores

SDM will target pro-Rx provinces for growth

TORONTO — Shoppers Drug Mart (SDM) will seek to expand in British Columbia and other provinces that compensate pharmacies for stepping up their role in the health care system. President and chief executive officer Jürgen Schreiber stated the company’s view as Ontario mulls regulations that could hurt pharmacy profits. “We see some provinces that are

Drug import proposal under fire

ALEXANDRIA, Va. — The National Association of Chain Drug Stores has expressed concerns with a proposed amendment to health care legislation because the provision would authorize the importation of prescription drugs. NACDS sent a letter to Rep. Louise McIntosh Slaughter (D., N.Y.), who chairs the House Rules Committee, and to Rep. David Drier (R., Cal­if.),

Use of FSAs is facilitated by

BELLEVUE, Wash. — Acknowledging the nearly 35 million Americans who have flexible spending accounts (FSAs) to cover their health care expenses, and who run the risk of losing their unused balances if they do not spend the funds by the end of the year, is highlighting a one-stop shopping web site that makes it

Generation Health is teaming up with CVS

WOONSOCKET, R.I. — CVS Caremark Corp. will be able to provide its pharmacy benefits management clients additional genetic services beginning in 2010 under a deal with Generation Health Inc. The agreement, under which CVS Caremark is taking a minority stake in privately held Generation Health, will expand pharmacogenomic clinical and testing services. Such initiatives can

Chain drug industry ready to fight H1N1

WASHINGTON — The National Association of Chain Drug Stores earlier this month told House subcommittees assessing the nation’s plans for distributing the H1N1 flu vaccine that the country’s drug stores can play a crucial role in ensuring that a maximum number of patients receive immunizations. “Community pharmacies are uniquely capable of immunizing large numbers of

Chain drug retailing’s events of the year

With 2009 winding down, the time has come to list the most memorable events of the year in chain drug retailing. Herewith, seven such events: • The remaking of Walgreens. Seldom in the annals of chain drug retailing has a retailer apparently at or near the top of its game so drastically and dramatically reversed

Coalition shines light on medication adherence

The day before the Senate leadership unveiled an $848 billion bill that will be the focal point of the next phase of the health care reform debate, all of the members of Congress received a timely reminder about the importance of including measures to improve medication compliance in whatever legislation is ultimately enacted. Twenty-seven organizations